MOLfile format is only available (V3000 format is not available)
Rchr
J-GLOBAL ID：200901057864607543
Update date: Aug. 30, 2024
Mitsui Tetsuo
Mitsui Tetsuo
Research field (2)：
Hematology and oncology
, Fetal medicine/Pediatrics
Research theme for competitive and other funds (7)：
2021 - 2025 Analyis of molecular characteristics of refractory/relapsed lymphoblastic lymphoma of children and young adult.
2016 - 2020 Searching leukemia predisposition gene in bone marrow failure syndrome with functional analysis.
2012 - 2016 Clinical and biological significance of granulocyte colony stimulating factor receptor gene abnormalities those found in severe congenital neutropenia.
2008 - 2011 Clinical and biological significance of granulocyte colony stimulating factor receptor gene abnormalities those found in severe congenital neutropenia
2005 - 2007 Clinical and biological significance of granulocyte colony stimulating factor receptor gene abnormalities those found in severe congenital neutropenia
2002 - 2003 Clinical and Biological Significance of Granulocyte-Colony-Stimulating-Factor Receptor Truncation Mutations in Severe Congenital Neutropenia.
1999 - 2000 Molecular Pathology of Hereditary Neuropathy
Show all
Papers (94)：
Masahiro Sekimizu, Fukano R, Koga Y, Mitsui T, Fujita N, Mori T, Hori D, Tanaka M, Ohki K, Iwafuchi H, et al. Rituximab-combined Anthracycline-free Chemotherapy in Newly Diagnosed Paediatric and Adolescent Patients with Non-high-risk Aggressive Mature B Cell Lymphoma: Protocol for a Single-arm, Open-label, Multicentre, Phase II Study (The Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20). BMJ Open. 2024
Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Takeshi Mori, Akiko M Saito, et al. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial. European journal of haematology. 2023
